A carregar...
Phosphodiesterase 5 inhibitors for pulmonary hypertension
BACKGROUND: Pulmonary hypertension (PH) comprises a group of complex and heterogenous conditions, characterised by elevated pulmonary artery pressure, and which left untreated leads to right‐heart failure and death. PH includes World Health Organisation (WHO) Group 1 pulmonary arterial hypertension...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2019
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6354064/ https://ncbi.nlm.nih.gov/pubmed/30701543 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012621.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|